Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

[Results of surgical revisions for ureteral complications after renal transplantation].

Abdo N, Murez T, Cabaniols L, Robert M, Marchal S, Amadane N, Thezenas S, Iborra F, Thuret R.

Prog Urol. 2019 Sep;29(10):474-481. doi: 10.1016/j.purol.2019.05.010. Epub 2019 Aug 7. French.

PMID:
31400962
2.

Photoluminescence Activation of Organic Dyes via Optically Trapped Quantum Dots.

Rodríguez-Rodríguez H, Acebrón M, Iborra FJ, Arias-Gonzalez JR, Juárez BH.

ACS Nano. 2019 Jun 25;13(6):7223-7230. doi: 10.1021/acsnano.9b02835. Epub 2019 Jun 13.

PMID:
31194513
3.

LONG-TERM OUTCOME OF RENAL TRANSPLANTATION IN PATIENTS WITH CONGENITAL LOWER URINARY TRACT MALFORMATIONS: A MULTICENTER STUDY.

Marchal S, Kalfa N, Iborra F, Badet L, Karam G, Broudeur L, Branchereau J, Abdo N, Thuret R.

Transplantation. 2019 Apr 4. doi: 10.1097/TP.0000000000002746. [Epub ahead of print]

PMID:
30964838
4.

An Alanine-to-Valine Substitution in the Residue 175 of Zika Virus NS2A Protein Affects Viral RNA Synthesis and Attenuates the Virus In Vivo.

Márquez-Jurado S, Nogales A, Ávila-Pérez G, Iborra FJ, Martínez-Sobrido L, Almazán F.

Viruses. 2018 Oct 7;10(10). pii: E547. doi: 10.3390/v10100547.

5.

Validating the RedMIT/GFP-LC3 Mouse Model by Studying Mitophagy in Autosomal Dominant Optic Atrophy Due to the OPA1Q285STOP Mutation.

Diot A, Agnew T, Sanderson J, Liao C, Carver J, Neves RPD, Gupta R, Guo Y, Waters C, Seto S, Daniels MJ, Dombi E, Lodge T, Morten K, Williams SA, Enver T, Iborra FJ, Votruba M, Poulton J.

Front Cell Dev Biol. 2018 Sep 19;6:103. doi: 10.3389/fcell.2018.00103. eCollection 2018.

6.

Author Correction: Osmotic modulation of chromatin impacts on efficiency and kinetics of cell fate modulation.

Lima AF, May G, Díaz-Colunga J, Pedreiro S, Paiva A, Ferreira L, Enver T, Iborra FJ, Pires das Neves R.

Sci Rep. 2018 Jul 23;8(1):11303. doi: 10.1038/s41598-018-29328-3.

7.

Osmotic modulation of chromatin impacts on efficiency and kinetics of cell fate modulation.

Lima AF, May G, Díaz-Colunga J, Pedreiro S, Paiva A, Ferreira L, Enver T, Iborra FJ, Pires das Neves R.

Sci Rep. 2018 May 8;8(1):7210. doi: 10.1038/s41598-018-25517-2. Erratum in: Sci Rep. 2018 Jul 23;8(1):11303.

8.

Mitochondrial levels determine variability in cell death by modulating apoptotic gene expression.

Márquez-Jurado S, Díaz-Colunga J, das Neves RP, Martinez-Lorente A, Almazán F, Guantes R, Iborra FJ.

Nat Commun. 2018 Jan 26;9(1):389. doi: 10.1038/s41467-017-02787-4.

9.

Nonsteroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk: results from the EPICAP study.

Doat S, Cénée S, Trétarre B, Rebillard X, Lamy PJ, Bringer JP, Iborra F, Murez T, Sanchez M, Menegaux F.

Cancer Med. 2017 Oct;6(10):2461-2470. doi: 10.1002/cam4.1186. Epub 2017 Sep 21.

10.

Calreticulin in Essential Thrombocythemia: StressINg OUT the Megakaryocyte Nucleus.

Iborra FJ, Papadopoulos P.

Front Oncol. 2017 May 22;7:103. doi: 10.3389/fonc.2017.00103. eCollection 2017.

11.

Renal graft intolerance syndrome in late graft failure patients: efficacy and safety of embolization as first-line treatment compared to surgical removal.

Al Badaai G, Pernin V, Garrigue V, Monnin V, Murez T, Fadli SED, Molinari N, Thuret R, Iborra F, Mourad G.

Transpl Int. 2017 May;30(5):484-493. doi: 10.1111/tri.12927. Epub 2017 Mar 5.

12.

[Urinary incontinence and sexual dysfunction after treatment of localized prostate cancer: Results from a population aged less than 65years old].

Bessaoud F, Orsini M, Iborra F, Rebillard X, Faix A, Soulier M, Daurès JP, Trétarre B.

Bull Cancer. 2016 Oct;103(10):829-840. doi: 10.1016/j.bulcan.2016.09.011. Epub 2016 Sep 29. French.

PMID:
27692730
13.

Mitochondria and the non-genetic origins of cell-to-cell variability: More is different.

Guantes R, Díaz-Colunga J, Iborra FJ.

Bioessays. 2016 Jan;38(1):64-76. doi: 10.1002/bies.201500082. Epub 2015 Dec 12. Review.

PMID:
26660201
14.

Facteurs de récidive après curage rétro-péritonéal pour tumeur germinale : étude rétrospective multicentrique.

Murez T, Durand X, Rivoire M, Fournier G, Dariane C, Rouprêt M, Lugagne J, Bosset P, Pignot G, Hetet J, Rigaud J, Safsaf R, Pfister C, Daste A, Sèbe P, Malavaud B, Bossavy J, Houlgatte A, Avances C, Camparo P, Flechon A, Culine S, Iborra F, Mottet N, Coloby P, Soulié M.

Prog Urol. 2014 Nov;24(13):865. doi: 10.1016/j.purol.2014.08.180. Epub 2014 Oct 30. French. No abstract available.

PMID:
26461706
15.

Global variability in gene expression and alternative splicing is modulated by mitochondrial content.

Guantes R, Rastrojo A, Neves R, Lima A, Aguado B, Iborra FJ.

Genome Res. 2015 May;25(5):633-44. doi: 10.1101/gr.178426.114. Epub 2015 Mar 23.

16.

Impact of graft nephrectomy on outcomes of second kidney transplantation.

Fadli SE, Pernin V, Nogue E, Macioce V, Picot MC, Ramounau-Pigot A, Garrigue V, Iborra F, Mourad G, Thuret R.

Int J Urol. 2014 Aug;21(8):797-802. doi: 10.1111/iju.12455. Epub 2014 Apr 13.

17.

TRAP1 regulates proliferation, mitochondrial function, and has prognostic significance in NSCLC.

Agorreta J, Hu J, Liu D, Delia D, Turley H, Ferguson DJ, Iborra F, Pajares MJ, Larrayoz M, Zudaire I, Pio R, Montuenga LM, Harris AL, Gatter K, Pezzella F.

Mol Cancer Res. 2014 May;12(5):660-9. doi: 10.1158/1541-7786.MCR-13-0481. Epub 2014 Feb 24.

18.

Epidemiological study of prostate cancer (EPICAP): a population-based case-control study in France.

Menegaux F, Anger A, Randrianasolo H, Mulot C, Laurent-Puig P, Iborra F, Bringer JP, Leizour B, Thuret R, Lamy PJ, Rébillard X, Trétarre B; EPICAP Study Group.

BMC Cancer. 2014 Feb 19;14:106. doi: 10.1186/1471-2407-14-106.

19.

[CCAFU Recommendations 2013: Testicular germ cell cancer].

Durand X, Rigaud J, Avancès C, Camparo P, Fléchon A, Murez T, Sèbe P, Culine S, Iborra F, Mottet N, Coloby P, Soulié M; Les membres du CCAFU.

Prog Urol. 2013 Nov;23 Suppl 2:S145-60. doi: 10.1016/S1166-7087(13)70052-6. French.

PMID:
24485289
20.

[CCAFU Recommendations 2013: Penile cancer].

Rigaud J, Avancès C, Camparo P, Durand X, Fléchon A, Murez T, Sèbe P, Coloby P, Culine S, Iborra F, Mottet N, Soulié M; Les membres du CCAFU.

Prog Urol. 2013 Nov;23 Suppl 2:S135-44. doi: 10.1016/S1166-7087(13)70051-4. French.

PMID:
24485288
21.

A biophysical model for transcription factories.

Canals-Hamann AZ, das Neves RP, Reittie JE, Iñiguez C, Soneji S, Enver T, Buckle VJ, Iborra FJ.

BMC Biophys. 2013 Feb 9;6:2. doi: 10.1186/2046-1682-6-2.

22.

Cord blood-derived CD34+ hematopoietic cells with low mitochondrial mass are enriched in hematopoietic repopulating stem cell function.

Romero-Moya D, Bueno C, Montes R, Navarro-Montero O, Iborra FJ, López LC, Martin M, Menendez P.

Haematologica. 2013 Jul;98(7):1022-9. doi: 10.3324/haematol.2012.079244. Epub 2013 Jan 24.

23.

A population-based analysis of the effect of marital status on overall and cancer-specific mortality in patients with squamous cell carcinoma of the penis.

Thuret R, Sun M, Budaus L, Abdollah F, Liberman D, Shariat SF, Iborra F, Guiter J, Patard JJ, Perrotte P, Karakiewicz PI.

Cancer Causes Control. 2013 Jan;24(1):71-9. doi: 10.1007/s10552-012-0091-y. Epub 2012 Oct 30.

PMID:
23109172
24.

Competing-risks analysis in patients with T1 squamous cell carcinoma of the penis.

Thuret R, Sun M, Abdollah F, Budaus L, Shariat SF, Iborra F, Guiter J, Patard JJ, Karakiewicz PI.

BJU Int. 2013 Apr;111(4 Pt B):E174-9. doi: 10.1111/j.1464-410X.2012.11505.x. Epub 2012 Oct 12.

25.

Pathologic findings in radical prostatectomy specimens from patients eligible for active surveillance with highly selective criteria: a multicenter study.

Beauval JB, Ploussard G, Soulié M, Pfister C, Van Agt S, Vincendeau S, Larue S, Rigaud J, Gaschignard N, Rouprêt M, Drouin S, Peyromaure M, Long JA, Iborra F, Vallancien G, Rozet F, Salomon L; Members of Committee of Cancerology of the French Association of Urology (CCAFU).

Urology. 2012 Sep;80(3):656-60. doi: 10.1016/j.urology.2012.04.051. Epub 2012 Jul 7.

PMID:
22770616
26.

Mitochondrial variability as a source of extrinsic cellular noise.

Johnston IG, Gaal B, Neves RP, Enver T, Iborra FJ, Jones NS.

PLoS Comput Biol. 2012;8(3):e1002416. doi: 10.1371/journal.pcbi.1002416. Epub 2012 Mar 8.

27.

Oncologic outcomes and survival in pT0 tumors after radical cystectomy in patients without neoadjuvant chemotherapy: results from a large multicentre collaborative study.

Rouprêt M, Drouin SJ, Larré S, Neuzillet Y, Botto H, Hitier M, Rigaud J, Crew J, Xylinas E, Salomon L, Cornu JN, Iborra F, Champetier D, Rozet F, Flamand V, Bastide C, Cormier L, Durand X, Lunardi P, Rischmann P, Nouhaud FX, Ferlicot S, Patard JJ, Floch AP, Irani J, Peyronnet B, Bensalah K, Poissonnier L, Grès P, Droupy S, Casenave J, Wallerand H, Soulié M, Pfister C; Bladder Cancer Committee of the French National Association of Urology (“CC-AFU Vessie”).

Ann Surg Oncol. 2011 Dec;18(13):3833-8. doi: 10.1245/s10434-011-1824-y. Epub 2011 Jun 7.

PMID:
21647762
28.

Conditional survival predictions after surgery for patients with penile carcinoma.

Thuret R, Sun M, Abdollah F, Schmitges J, Shariat SF, Iborra F, Guiter J, Patard JJ, Perrotte P, Karakiewicz PI.

Cancer. 2011 Aug 15;117(16):3723-30. doi: 10.1002/cncr.25974. Epub 2011 Feb 24.

29.

Connecting variability in global transcription rate to mitochondrial variability.

das Neves RP, Jones NS, Andreu L, Gupta R, Enver T, Iborra FJ.

PLoS Biol. 2010 Dec 14;8(12):e1000560. doi: 10.1371/journal.pbio.1000560.

30.

Tumor grade improves the prognostic ability of American Joint Committee on Cancer stage in patients with penile carcinoma.

Thuret R, Sun M, Abdollah F, Budaus L, Lughezzani G, Liberman D, Morgan M, Johal R, Jeldres C, Latour M, Shariat SF, Iborra F, Guiter J, Patard JJ, Perrotte P, Karakiewicz PI.

J Urol. 2011 Feb;185(2):501-7. doi: 10.1016/j.juro.2010.09.111. Epub 2010 Dec 17.

PMID:
21167526
31.

[Recommendations Onco-Urology 2010: Germ cell testicular tumors.].

Durand X, Rigaud J, Avances C, Camparo P, Culine S, Iborra F, Mottet N, Sèbe P, Soulié M; Oncology Committee of the French Association of Urology (CCAFU).

Prog Urol. 2010 Nov;20 Suppl 4:S297-309. doi: 10.1016/S1166-7087(10)70046-4. French. No abstract available.

PMID:
21129648
32.

[Recommendations Onco-Urology 2010: Malignancies of the penis].

Rigaud J, Avancès C, Camparo P, Culine S, Durand X, Iborra F, Mottet N, Sèbe P, Soulié M; Oncology Committee of the French Association of Urology (CCAFU).

Prog Urol. 2010 Nov;20 Suppl 4:S279-89. doi: 10.1016/S1166-7087(10)70044-0. French. No abstract available.

PMID:
21129646
33.

A pilot study of gemcitabine in combination with oxaliplatin and vinorelbine in patients with metastatic bladder cancer.

Pouessel D, Huguet H, Iborra F, Rebillard X, Ayuso D, Becht C, Culine S.

Anticancer Res. 2010 Nov;30(11):4711-5.

PMID:
21115929
34.

Alpha-MSH regulates intergenic splicing of MC1R and TUBB3 in human melanocytes.

Dalziel M, Kolesnichenko M, das Neves RP, Iborra F, Goding C, Furger A.

Nucleic Acids Res. 2011 Mar;39(6):2378-92. doi: 10.1093/nar/gkq1125. Epub 2010 Nov 11.

35.

A contemporary population-based assessment of the rate of lymph node dissection for penile carcinoma.

Thuret R, Sun M, Lughezzani G, Budaus L, Liberman D, Abdollah F, Morgan M, Johal R, Jeldres C, Latour M, Shariat SF, Iborra F, Guiter J, Patard JJ, Perrotte P, Karakiewicz PI.

Ann Surg Oncol. 2011 Feb;18(2):439-46. doi: 10.1245/s10434-010-1315-6. Epub 2010 Sep 14.

PMID:
20839061
36.

Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice.

Fritz V, Benfodda Z, Rodier G, Henriquet C, Iborra F, Avancès C, Allory Y, de la Taille A, Culine S, Blancou H, Cristol JP, Michel F, Sardet C, Fajas L.

Mol Cancer Ther. 2010 Jun;9(6):1740-54. doi: 10.1158/1535-7163.MCT-09-1064. Epub 2010 Jun 8.

37.

MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU.

Favaro E, Ramachandran A, McCormick R, Gee H, Blancher C, Crosby M, Devlin C, Blick C, Buffa F, Li JL, Vojnovic B, Pires das Neves R, Glazer P, Iborra F, Ivan M, Ragoussis J, Harris AL.

PLoS One. 2010 Apr 26;5(4):e10345. doi: 10.1371/journal.pone.0010345.

38.

miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice.

Clapé C, Fritz V, Henriquet C, Apparailly F, Fernandez PL, Iborra F, Avancès C, Villalba M, Culine S, Fajas L.

PLoS One. 2009 Oct 26;4(10):e7542. doi: 10.1371/journal.pone.0007542.

39.

GFI1B controls its own expression binding to multiple sites.

Anguita E, Villegas A, Iborra F, Hernández A.

Haematologica. 2010 Jan;95(1):36-46. doi: 10.3324/haematol.2009.012351. Epub 2009 Sep 22.

40.

[Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault].

Jegu J, Tretarre B, Grosclaude P, Rebillard X, Bataille V, Malavaud B, Iborra F, Salama G, Rischmann P, Villers A.

Prog Urol. 2009 Jul;19(7):487-98. doi: 10.1016/j.purol.2009.03.001. Epub 2009 Apr 28. French.

PMID:
19559380
41.

[Prognostic factors in renal cell carcinoma].

Letang N, Cabaniols L, Pouessel D, Robert M, Iborra F, Culine S, Patard JJ, Guiter J, Thuret R.

Bull Cancer. 2009 Apr;96(4):475-84. doi: 10.1684/bdc.2009.0845. Review. French.

42.

[Treatment of primary urethral carcinoma. Guidelines from the French Urological Association. Cancer committee].

Iborra F, Rigaud J, Bastide C, Mottet N; les membres du sous-comité organes génitaux externes du comité de cancérologie de l'AFU.

Prog Urol. 2009 Mar;19(3):170-5. doi: 10.1016/j.purol.2008.12.003. Epub 2009 Feb 10. Review. French.

PMID:
19268254
43.

[Metastases from squamous cell carcinoma of the penis].

Iborra F, Neuzillet Y, Méjean A, Lebret T.

Prog Urol. 2008 Nov;18 Suppl 7:S392-5. doi: 10.1016/S1166-7087(08)74572-X. French.

PMID:
19070821
44.

Association between active genes occurs at nuclear speckles and is modulated by chromatin environment.

Brown JM, Green J, das Neves RP, Wallace HA, Smith AJ, Hughes J, Gray N, Taylor S, Wood WG, Higgs DR, Iborra FJ, Buckle VJ.

J Cell Biol. 2008 Sep 22;182(6):1083-97. doi: 10.1083/jcb.200803174.

45.

Characterization of megakaryocyte GATA1-interacting proteins: the corepressor ETO2 and GATA1 interact to regulate terminal megakaryocyte maturation.

Hamlett I, Draper J, Strouboulis J, Iborra F, Porcher C, Vyas P.

Blood. 2008 Oct 1;112(7):2738-49. doi: 10.1182/blood-2008-03-146605. Epub 2008 Jul 14.

46.

Partial recovery of delayed graft function due to cholesterol emboli after renal transplantation.

Ackoundou-N'Guessan C, Bismuth J, Canet S, Iborra F, Mourad G.

Saudi J Kidney Dis Transpl. 2008 Jul;19(4):631-5.

PMID:
18580026
47.

Cytogenetic studies of 24 renal epithelial tumors with von Hippel-Lindau and fragile histidine triad protein expression correlation.

Gayrard N, Cacheux V, Iborra F, Mourad G, Argilés A.

Arch Pathol Lab Med. 2008 Jun;132(6):965-73. doi: 10.1043/1543-2165(2008)132[965:CSORET]2.0.CO;2.

PMID:
18517280
48.

Prostate cancer in renal transplant recipients.

Kleinclauss F, Gigante M, Neuzillet Y, Mouzin M, Terrier N, Salomon L, Iborra F, Petit J, Cormier L, Lechevallier E; Renal Transplantation Committee of the French Urological Association (AFU).

Nephrol Dial Transplant. 2008 Jul;23(7):2374-80. doi: 10.1093/ndt/gfn008. Epub 2008 Feb 18.

PMID:
18283085
49.

[What about lombo-aortic curage in the treatment of testicle cancer?].

Iborra F, Avances C, Culine S, Houlgatte A, Mottete N.

Ann Urol (Paris). 2007 Jun;41(3):116-26. Review. French.

PMID:
18260272
50.

[Study of apoptosis and mitosis mechanisms in the eye. Experimental model of gestational toxic syndrome].

Pons-Vázquez S, Vila-Bou V, Zanon-Moreno V, Iborra FJ, Gallego-Pinazo R, Melo PM, García-Medina JJ, Pinazo-Durán MD.

Arch Soc Esp Oftalmol. 2008 Jan;83(1):37-44. Spanish.

Supplemental Content

Loading ...
Support Center